Oral communications and exchanges (Session 13 – 16)

CO-13-1: Edgard DABIRA:
Field performance of the highly sensitive rapid diagnostic test for detecting low-density Plasmodium falciparum infections in The Gambia

CO-14-1: Issiaka SARE: 
Investigation sur la dynamique et le tropisme cellulaire du champignons endosymbionte Microsporidia MB dans la lutte contre le paludisme au Burkina Faso

CO-15-1: Abou COULIBALY: Effects of the application PANDA (Pregnancy and Newborn Diagnostic Assessment) on the quality of prenatal care in Burkina Faso: a randomized controlled clinical trial

CO-16-1: Abdou Azaque ZOURÉ:
Study of genetic mutations
in patients with cancer over a
10-year period in Burkina Faso

CO-13-2: Amélé Fifi Chantal KOUEVI:
Malaria parasite species composition in clinical and asymptomatic infections among children under coverage of seasonal malaria chemoprevention in the health district of Nanoro, Burkina Faso

CO-14-2: P. D. Tatiana LALLOGO:
The KIR2DL5B and HLA DRB1*12 alleles appear to be associated with protection against HIV-1 in serodiscordant couples in Burkina Faso in 2021

CO-15-2: Fatima Tima Alice SANOU:
Psychomotor Development, Growth, and Susceptibility to Infections in the First Year of Life of Children Exposed to Antimalarial Drugs During Pregnancy

CO-16-2: Abdoulaye HAROUNA:
Analysis of surveillance data on acute malnutrition in children aged 6 to 59 months, Tahoua Region, Niger, 2017-2022

CO-13-3: Doubé Lucien LAMY:
Entomopathogenic fungi
Metarhizium pingshaense
increases susceptibility to insecticides in highly resistant malaria mosquitoes Anopheles coluzzii

CO-14-3: Ter Tiero Elias DAH: The cascade of HIV pre-exposure prophylaxis through oral administration in Burkina Faso

CO-15-3: Hamtandi Magloire NATAMA: Efficacy of the RH5.1/Matrix-M™ blood-stage malaria vaccine candidate against clinical P. falciparum malaria in children aged 5-17 months in Burkina Faso

CO-16-3: Djè Djènéba Aïda TRAORE: 
Valeur diagnostique potentielle des micro-ARN urinaires, plasmatiques et sériques miR-21, miR-141 et miR￾375 dans le cancer de la prostate : revue systématique et méta-analyse 

CO-13-4: Hamadou KONATE: Effectiveness of essential oils against Anopheles gambiae s.l. populations in two health districts of Burkina Faso: Solenzo and Soumousso

CO-14-4: Sanhitouo Charlemagne DABIRE: Resistance Profile of Enterobacter cloacae, a potentially pathogenic enterobacterium isolated from three biotopes in the city of Ouagadougou and its surroundings, Burkina Faso

CO-15-4: Wend Kouni Charles ZOUNGRANA: Analysis of serious adverse events during the clinical trial RTS,S/SMC conducted in Houndé, Burkina Faso

CO-16-4: Tangbadioa Hervé
COULIDIATI:
Role of miRNAs in the resistance of prostate cancer cells to docetaxel

CO-13-5: Kadija OUÉDRAOGO: Acceptability of a screening and treatment strategy for the population in the context of strengthening the impact of the Primary Health Care (CPS) in Burkina Faso

CO-14-5: Cathérine SAWADOGO:
Surveillance of influenza viruses and SARS-CoV-2 in Burkina Faso during the post-pandemic period of COVID-19

CO-15-5: Maïmouna Cherifatou SORY:
Analysis of the Process of Obtaining Clinical Trial Authorization: Case of the Clinical Research Unit of Nanoro (Burkina Faso)

CO-16-5: Pamela BORGES:
Molecular biology lab implementation at Agostinho Neto Hospital, Cabo Verde for breast cancer diagnoses and research: achievements, difficulties, and lessons

CO-14-6: Abdoulaye ZANNE:
Analysis of immunological parameters in suspected dengue cases received at the National Public Health Laboratory.

CO-15-6: Moussa LINGANI:
Safety and efficacy of KAF156 (ganaplacide) combined with the solid dispersion formulation of lumefantrine (LUM-SDF) in patients with uncomplicated Plasmodium falciparum malaria: a multicenter randomized phase 2 clinical trial.

CO-16-6: Ourohiré MILLOGO:
Factors Associated with Anemia in School-Aged Adolescents in Burkin